Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Knatterud

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
JAMA|July 7, 1978
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatmentG L Knatterud, C R Klimt, M E Levin, et al.
Circulation|December 1, 1996
Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction. Observations from the TIMI IIIB TrialD O Williams, E Braunwald, B Thompson, et al.
Journal of the American College of Cardiology|October 1, 1995
Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI InvestigatorsH S Mueller, S A Forman, M A Menegus, et al.
QJM : Monthly Journal of the Association of Physicians|April 6, 2006
Presenting characteristics as predictors of duration of treatment in sarcoidosisR P Baughman, M A Judson, A Teirstein, et al.
Journal of the American College of Cardiology|December 1, 1990
Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research GroupF Feit, H S Mueller, E Braunwald, et al.
Annals of Internal Medicine|April 15, 1994
Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction InvestigatorsR C Becker, M Terrin, R Ross, et al.
Diabetes Care|May 1, 1985
The course of peripheral vascular disease in non-insulin-dependent diabetesK Kreines, E Johnson, M Albrink, et al.
Journal of the American College of Cardiology|November 1, 1992
Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study GroupG H Tofler, J E Muller, P H Stone, et al.
The American Journal of Cardiology|April 1, 1997
Anginal status and prediction of cardiac events in patients enrolled in the asymptomatic cardiac ischemia pilot (ACIP) study. ACIP investigatorsC R Conti, N L Geller, G L Knatterud, et al.
Journal of the American College of Cardiology|July 1, 1995
Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study GroupB L Zaret, F J Wackers, M L Terrin, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
JAMA|July 7, 1978
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatmentG L Knatterud, C R Klimt, M E Levin, et al.
Circulation|December 1, 1996
Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction. Observations from the TIMI IIIB TrialD O Williams, E Braunwald, B Thompson, et al.
Journal of the American College of Cardiology|October 1, 1995
Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI InvestigatorsH S Mueller, S A Forman, M A Menegus, et al.
QJM : Monthly Journal of the Association of Physicians|April 6, 2006
Presenting characteristics as predictors of duration of treatment in sarcoidosisR P Baughman, M A Judson, A Teirstein, et al.
Journal of the American College of Cardiology|December 1, 1990
Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research GroupF Feit, H S Mueller, E Braunwald, et al.
Annals of Internal Medicine|April 15, 1994
Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction InvestigatorsR C Becker, M Terrin, R Ross, et al.
Diabetes Care|May 1, 1985
The course of peripheral vascular disease in non-insulin-dependent diabetesK Kreines, E Johnson, M Albrink, et al.
Journal of the American College of Cardiology|November 1, 1992
Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study GroupG H Tofler, J E Muller, P H Stone, et al.
The American Journal of Cardiology|April 1, 1997
Anginal status and prediction of cardiac events in patients enrolled in the asymptomatic cardiac ischemia pilot (ACIP) study. ACIP investigatorsC R Conti, N L Geller, G L Knatterud, et al.
Journal of the American College of Cardiology|July 1, 1995
Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study GroupB L Zaret, F J Wackers, M L Terrin, et al.
Pageof 8